Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MICAFUNGIN vs REZAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MICAFUNGIN vs REZAFUNGIN: Safety Overview

Metric MICAFUNGIN REZAFUNGIN
Total FAERS Reports 3,117 108
Deaths Reported 1,068 12
Death Rate 34.3% 11.1%
Hospitalizations 1,121 20
Average Patient Age 49.7 yrs 53.8 yrs
% Female Patients 38.7% 54.3%
FDA Approval Date Apr 3, 2025 Mar 22, 2023
Manufacturer Zydus Pharmaceuticals USA Inc. Melinta Therapeutics, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription